The recent run up in MindMed’s (MNMD) stock price due to it’s NASDAQ uplisting has led the company to surpass Compass Pathways (CMPS) as the largest psychedelics company based on market capitalization. At a market capitalization of $1.52 billion as of April 28, 2021, MindMed is valued at more than 14% larger than Compass Pathways’ $1.32…